Statin-induced structural changes in coronary plaques evaluated by intracoronary imaging

Circulation Journal

Volumn 73, Issue 4, 2009, Pages 628-629

  Komiyama, Nobuyuki ^a  

^a SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PITAVASTATIN; ROSUVASTATIN;

ACUTE CORONARY SYNDROME; ANGIOSCOPY; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; DRUG MECHANISM; EDITORIAL; HUMAN; IMAGE ANALYSIS; INTRAVASCULAR ULTRASOUND; NONHUMAN; QUANTITATIVE ANALYSIS;

AGED; ANGIOSCOPY; ANTICHOLESTEREMIC AGENTS; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; PYRROLES; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 65649139594     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0067     Document Type: Editorial

References (15)

1. O'Keefe JR JH, Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70 mg/dL: Lower is better and physiologically normal. J Am Coll Cardiol 2004; 43: 2142-2146. (Pubitemid 38686815)
2. Shiomi M, Ito T, Tsukada T, Yata T, Watanabe Y, Tsujita Y, et al. Reduction of serum-cholesterol levels alters lesional composition of atherosclerotic plaques: Effects of pravastatin sodium on atherosclerosis in mature WHHL rabbits. Arterioscler Thromb Vasc Biol 1995; 15: 1938-1944.
3. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004; 291: 1071-1080. (Pubitemid 38541684)
4. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis. JAMA 2006; 295: 1556-1565.
5. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, et al. Volumetric intravascular ultrasound analysis during half a year after coronary event: The ESTABLISH study. Circulation 2004; 110: 1061-1068.
6. Takashima H, Ozaki Y, Yasukawa T, Waseda K, Asai K, Wakita Y, et al. Impact of lipid-lowering therapy with pitavastatin, a new HMG-CoA reductases inhibitor, on regression of coronary atherosclerotic plaque: A 3-dimensional intravascular ultrasound study. Circ J 2007; 71: 1678-1684. (Pubitemid 350240085)
7. von Birgelen C, Hartmann M, Mintz GS, van Houwelingen KG, Deppermann N, Schmermund A, et al. Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation 2004; 110: 1579-1585. (Pubitemid 39297979)
8. Okubo M, Kawasaki M, Ishihara Y, Takeyama U, Yasuda S, Kubota T, et al. Tissue characterization of coronary plaques: Comparison of integrated backscatter intravascular ultrasound with virtual histology intravascular ultrasound. Circ J 2008; 72: 1631-1639.
9. Yokoyama M, Komiyama N, Courtney BK, Nakayama T, Namikawa S, Kuriyama N, et al. Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: A randomized prospective study. Am Heart J 2005; 150: e1-e287. (Pubitemid 41121948)
10. Kawasaki M, Sano K, Okubo M, Yokoyama H, Ito Y, Murata I, et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2005; 45: 1946-1953.
11. Komiyama N, Nishiyama S, Nakanishi S, Seki A. Intravascular imaging of serial changes of disease in saphenous vein grafts after coronary artery bypass grafting. Am Heart J 1996; 132: 30-40. (Pubitemid 26243689)
12. Inami S, Ishibashi F, Waxman S, Okamatsu K, Seimiya K, Takano M, et al. Multiple yellow plaques assessed by angioscopy with quantitative colorimetry in patients with myocardial infarction. Circ J 2008; 72: 399-403.
13. Takano M, Mizuno K, Yokoyama S, Seimiya K, Ishibashi F, Okamatsu K, et al. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: Serial evaluation by coronary angioscopy. J Am Coll Cardiol 2003; 42: 680-686. (Pubitemid 37000185)
14. Hirayama A, Saito S, Ueda Y, Takayama T, Honye J, Komatsu S, et al. Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy. Circ J 2009; 73: 718-725.
15. Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Chen MS, Crowe T, et al. Paradoxical increase in lumen size during progression of coronary atherosclerosis: Observation from the REVERSAL trial. Atherosclerosis 2006; 189: 229-235. (Pubitemid 44441288)